Synergena, Inc. announced a significant achievement with the use of biophotonics to destroy pathogenic
microorganisms. Utilizing
Bacillus subtilis spores as surrogate for the pathogen
Bacillus anthracis (
anthrax), Synergena's SIAD process killed the airborne and powder
spores in under 10 seconds.
The SIAD process was able to penetrate biological containment
filters, totally destroy all
Bacillus subtilis spores, and preserve the integrity of the
filters. In addition, the SIAD process penetrated a sealed envelope killing all the surrogate
microorganisms during testing at the Michael A. Meenaghan Science Center, State University of New York at Buffalo.
The patented SIAD (Synergistic Inactivation And Disinfection) process culminates from over 20 years of biophotonic research by the Florida/New York company, Synergena. Previously, the SIAD process has achieved success in research studies involving sterilizing implantable devices for
clinical trials at Roswell Park Cancer Institute, The
Cleveland Clinic, Veterans Administrative Centers, and
Louisiana State University.
Synergena President, Robert E. Duthie, stated: ``The success of the trials at SUNY's Meenaghan Center are significant because (1) the technology developed from our medical research can be transferred to commercial applications, and (2) the tests demonstrated the use of the SIAD technology in economical, efficient and practical applications for today's air handling systems.''